{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:07:07Z","timestamp":1750133227617,"version":"3.41.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Adrenocortical carcinoma is a very rare oncologic condition with poor prognosis that usually metastasizes to the lungs, liver, local lymph nodes, and peritoneum at initial presentation. However, skin metastasis is very uncommon and has rarely been reported even in advanced stages of the disease. We present a case of a 41-year-old man with a known history of adrenocortical carcinoma of the right adrenal gland that presented with an arm mass. The histopathologic sections showed a multinodular necrotic malignant neoplasm in dermis and subcutaneous fat composed of atypical epithelioid cells with ample granular cytoplasm and pleomorphic vesicular nuclei with frequent intranuclear inclusions and atypical mitoses. The immunohistochemical stains showed tumor cells that were strongly positive for synaptophysin and inhibin, only focally positive for Melan-A, and negative for AE1\/AE3. The histopathologic features and the immunohistochemical profile confirmed the diagnosis of metastatic carcinoma consistent with adrenal cortical origin. The diagnosis can be difficult (especially when no clinical data are provided), and an immunohistochemical battery is often useful in distinguishing this tumor from other tumors with similar cytomorphological features.<\/jats:p>","DOI":"10.1097\/dad.0000000000002816","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T19:00:35Z","timestamp":1723662035000},"page":"696-699","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Metastatic Adrenocortical Carcinoma to the Skin: A Case Report and Review of This Unusual Neoplasm"],"prefix":"10.1097","volume":"46","author":[{"given":"Efrain","family":"Lee-Diaz","sequence":"first","affiliation":[{"name":"Division of Dermatopathology, Department of Pathology, The Ohio State University Wexner Medical Center (OSUWMC), Columbus, OH; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Contreras","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center (OSUWMC), Columbus, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Plaza","sequence":"additional","affiliation":[{"name":"Division of Dermatopathology, Department of Pathology, The Ohio State University Wexner Medical Center (OSUWMC), Columbus, OH; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y","article-title":"Risk factors for adrenal cancer: an exploratory study","volume":"65","author":"Hsing","year":"1996","journal-title":"Int J Cancer."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2015.00045","article-title":"Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment","volume":"3","author":"Libe","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/cncr.31916","article-title":"The who, when, and why of primary adrenal malignancies: insights into the epidemiology of a rare clinical entity","volume":"125","author":"Chandrasekar","year":"2019","journal-title":"Cancer."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: a United States population based study","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.2147\/OTT.S147352","article-title":"Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database","volume":"10","author":"Wang","year":"2017","journal-title":"Onco Targets Ther."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/biomedicines9020175","article-title":"Adrenocortical carcinoma: updates of clinical and pathological features after renewed world health organisation classification and pathology staging","volume":"9","author":"Lam","year":"2021","journal-title":"Biomedicines."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assie","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1600-0560.2007.00870.x","article-title":"Adrenocortical carcinoma with delayed cutaneous metastasis","volume":"35","author":"Satter","year":"2008","journal-title":"J Cutan Pathol."},{"key":"R12-20250616","first-page":"42","article-title":"Cutaneous metastasis disclosing adrenal cortical carcinoma [in French]","volume":"121","author":"Roudier","year":"1994","journal-title":"Ann Dermatol Venereol."},{"key":"R13-20250616","first-page":"330","article-title":"Cutaneous adrenal cortical carcinoma metastasis in a 6 year-old boy","volume":"29","author":"Brau-Javier","year":"2010","journal-title":"P R Health Sci J."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5999\/aps.2013.40.5.645","article-title":"Solitary labial metastasis of adrenocortical carcinoma resembling a cystic tumor in a child","volume":"40","author":"Song","year":"2013","journal-title":"Arch Plast Surg."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/1097-0142(19910615)67:12<3087::AID-CNCR2820671225>3.0.CO;2-D","article-title":"Adrenal carcinoma presenting as a lesion resembling cutaneous angiosarcoma","volume":"67","author":"Milchgrub","year":"1991","journal-title":"Cancer."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1097-0142(19880801)62:3<507::AID-CNCR2820620311>3.0.CO;2-8","article-title":"Spontaneously regressing adrenocortical carcinoma in a newborn. A case report with DNA ploidy analysis","volume":"62","author":"Saracco","year":"1988","journal-title":"Cancer."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12957-015-0527-4","article-title":"Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature","volume":"13","author":"Wanis","year":"2015","journal-title":"World J Surg Oncol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.21037\/tcr.2019.12.28","article-title":"Adrenocortical carcinoma: a literature review","volume":"9","author":"Thampi","year":"2020","journal-title":"Transl Cancer Res."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/biomedicines9020174","article-title":"The role of biomarkers in adrenocortical carcinoma: a review of current evidence and future perspectives","volume":"9","author":"Mizdrak","year":"2021","journal-title":"Biomedicines"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.humpath.2012.07.025","article-title":"Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates","volume":"44","author":"Duregon","year":"2013","journal-title":"Hum Pathol."},{"key":"R22-20250616","first-page":"1160","article-title":"A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors","volume":"11","author":"Renshaw","year":"1998","journal-title":"Mod Pathol."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAI.0b013e31828a96cf","article-title":"Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases","volume":"22","author":"Weissferdt","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.MP.0000073134.60541.E8","article-title":"The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study","volume":"16","author":"Zhang","year":"2003","journal-title":"Mod Pathol."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00129039-200312000-00009","article-title":"Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas","volume":"11","author":"Ghorab","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/PAS.0b013e3182152629","article-title":"Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases","volume":"35","author":"Sangoi","year":"2011","journal-title":"Am J Surg Pathol."},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/PAI.0b013e3181ddf7b9","article-title":"Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers","volume":"18","author":"Lapinski","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"R28-20250616","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/cancers12030602","article-title":"Comprehensive immunoprofiles of renal cell carcinoma subtypes","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers (Basel)."},{"key":"R29-20250616","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:00:55Z","timestamp":1750096855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002816","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}